Stay updated with breaking news from Faron Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Faron Pharmaceuticals Ltd on Monday noted a positive read-out regarding the ongoing Bexmab trial on myelodysplastic syndrome, a form of cancer. The Turku, Finland-based clinical-stage...
Faron Pharma’s latest results from the BEXMAB trial in aggressive myeloid leukaemias (a rare blood cancer) showed more promising results, according to...
One of the week's biggest casualties was Inland Homes , where forecast losses are now expected to be in the range of £90million, up from £37million.
Stop watching that documentary on slow-drying paint and check out the London stock market instead
Stop watching that documentary on slow-drying paint and check out the London stock market instead